
John S. Brusca
Examiner (ID: 15745)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1636, 1631, 1805, 1672, 1621 |
| Total Applications | 1495 |
| Issued Applications | 870 |
| Pending Applications | 179 |
| Abandoned Applications | 449 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4327882
[patent_doc_number] => 06312922
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Complementary DNAs'
[patent_app_type] => 1
[patent_app_number] => 9/247155
[patent_app_country] => US
[patent_app_date] => 1999-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 117855
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312922.pdf
[firstpage_image] =>[orig_patent_app_number] => 247155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/247155 | Complementary DNAs | Feb 8, 1999 | Issued |
Array
(
[id] => 4349462
[patent_doc_number] => 06291237
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Cancer diagnosis and therapy based on mutations in TGF-.beta. receptors'
[patent_app_type] => 1
[patent_app_number] => 9/239864
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 18561
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291237.pdf
[firstpage_image] =>[orig_patent_app_number] => 239864
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/239864 | Cancer diagnosis and therapy based on mutations in TGF-.beta. receptors | Jan 28, 1999 | Issued |
Array
(
[id] => 946536
[patent_doc_number] => 06964868
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-15
[patent_title] => 'Human genes and gene expression products II'
[patent_app_type] => utility
[patent_app_number] => 09/297648
[patent_app_country] => US
[patent_app_date] => 1999-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 209175
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964868.pdf
[firstpage_image] =>[orig_patent_app_number] => 09297648
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/297648 | Human genes and gene expression products II | Jan 27, 1999 | Issued |
Array
(
[id] => 4264921
[patent_doc_number] => 06306595
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Design of drugs involving receptor-ligand-DNA interactions'
[patent_app_type] => 1
[patent_app_number] => 9/239491
[patent_app_country] => US
[patent_app_date] => 1999-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11615
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306595.pdf
[firstpage_image] =>[orig_patent_app_number] => 239491
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/239491 | Design of drugs involving receptor-ligand-DNA interactions | Jan 27, 1999 | Issued |
| 09/238530 | THERAPEUTIC COMPOSITIONS CONTAINING GLUTATHIONE ANALOGS | Jan 26, 1999 | Abandoned |
Array
(
[id] => 6208389
[patent_doc_number] => 20020071848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'VIRUS VACCINES'
[patent_app_type] => new
[patent_app_number] => 09/235901
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9216
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20020071848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09235901
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235901 | VIRUS VACCINES | Jan 21, 1999 | Abandoned |
Array
(
[id] => 4251390
[patent_doc_number] => 06222018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Hypoxia inducible factor-1 and method of use'
[patent_app_type] => 1
[patent_app_number] => 9/235217
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 36
[patent_no_of_words] => 18976
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/222/06222018.pdf
[firstpage_image] =>[orig_patent_app_number] => 235217
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235217 | Hypoxia inducible factor-1 and method of use | Jan 21, 1999 | Issued |
Array
(
[id] => 1565379
[patent_doc_number] => 06376236
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Recombinant alphavirus particles'
[patent_app_type] => B1
[patent_app_number] => 09/236140
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 37
[patent_no_of_words] => 84743
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09236140
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/236140 | Recombinant alphavirus particles | Jan 21, 1999 | Issued |
| 09/231834 | HIGHLY PRODUCTIVE PACKAGING LINES | Jan 14, 1999 | Abandoned |
Array
(
[id] => 1534370
[patent_doc_number] => 06489138
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Human ependymin'
[patent_app_type] => B1
[patent_app_number] => 09/229583
[patent_app_country] => US
[patent_app_date] => 1999-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 36345
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489138.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229583
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229583 | Human ependymin | Jan 12, 1999 | Issued |
Array
(
[id] => 1399566
[patent_doc_number] => 06534261
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins'
[patent_app_type] => B1
[patent_app_number] => 09/229037
[patent_app_country] => US
[patent_app_date] => 1999-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 32312
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534261.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229037
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229037 | Regulation of endogenous gene expression in cells using zinc finger proteins | Jan 11, 1999 | Issued |
Array
(
[id] => 1484266
[patent_doc_number] => 06453242
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites'
[patent_app_type] => B1
[patent_app_number] => 09/229007
[patent_app_country] => US
[patent_app_date] => 1999-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 24661
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/453/06453242.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229007 | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites | Jan 11, 1999 | Issued |
Array
(
[id] => 7605945
[patent_doc_number] => 07099777
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-29
[patent_title] => 'Techniques for identifying confirming mapping and categorizing nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 09/229060
[patent_app_country] => US
[patent_app_date] => 1999-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 6694
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/099/07099777.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229060
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229060 | Techniques for identifying confirming mapping and categorizing nucleic acids | Jan 10, 1999 | Issued |
Array
(
[id] => 1474248
[patent_doc_number] => 06387697
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Compositions for treatment and diagnosis of breast cancer and methods for their use'
[patent_app_type] => B1
[patent_app_number] => 09/222575
[patent_app_country] => US
[patent_app_date] => 1998-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13322
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387697.pdf
[firstpage_image] =>[orig_patent_app_number] => 09222575
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222575 | Compositions for treatment and diagnosis of breast cancer and methods for their use | Dec 27, 1998 | Issued |
Array
(
[id] => 1484255
[patent_doc_number] => 06453241
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Method and system for analyzing biological response signal data'
[patent_app_type] => B1
[patent_app_number] => 09/220276
[patent_app_country] => US
[patent_app_date] => 1998-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 24129
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/453/06453241.pdf
[firstpage_image] =>[orig_patent_app_number] => 09220276
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/220276 | Method and system for analyzing biological response signal data | Dec 22, 1998 | Issued |
Array
(
[id] => 6860984
[patent_doc_number] => 20030091992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'UNIVERSAL COLLECTION MEDIUM'
[patent_app_type] => new
[patent_app_number] => 09/210031
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7046
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09210031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210031 | Universal collection medium | Dec 10, 1998 | Issued |
Array
(
[id] => 728144
[patent_doc_number] => 07041490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-09
[patent_title] => 'Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same'
[patent_app_type] => utility
[patent_app_number] => 09/201228
[patent_app_country] => US
[patent_app_date] => 1998-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 84521
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09201228
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/201228 | Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same | Nov 29, 1998 | Issued |
Array
(
[id] => 1435768
[patent_doc_number] => 06355411
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Virulence-associated nucleic acid sequences and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/199637
[patent_app_country] => US
[patent_app_date] => 1998-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 171
[patent_no_of_words] => 26272
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355411.pdf
[firstpage_image] =>[orig_patent_app_number] => 09199637
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/199637 | Virulence-associated nucleic acid sequences and uses thereof | Nov 24, 1998 | Issued |
Array
(
[id] => 1317860
[patent_doc_number] => 06605448
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-12
[patent_title] => 'Method and means for sorting and identifying biological information'
[patent_app_type] => B1
[patent_app_number] => 09/193390
[patent_app_country] => US
[patent_app_date] => 1998-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14071
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605448.pdf
[firstpage_image] =>[orig_patent_app_number] => 09193390
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/193390 | Method and means for sorting and identifying biological information | Nov 17, 1998 | Issued |
| 09/191747 | RECOMBINANT ALPHAVIRUS VECTORS | Nov 11, 1998 | Abandoned |